US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 91.810
  • +0.370+0.40%
Trading Aug 9 10:21 ET
5.82BMarket Cap-26923P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
139.98%138.16M
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
172.77%65.98M
Operating revenue
139.98%138.16M
51.87%96.12M
22.22%249.38M
85.55%71.96M
-14.26%56.57M
57.52%57.57M
0.89%63.29M
13.30%204.04M
-63.76%38.78M
172.77%65.98M
Cost of revenue
226.86%7.59M
0.50%3.19M
-52.06%8.54M
-94.64%260K
-7.27%2.78M
-52.46%2.32M
-37.49%3.18M
-0.67%17.81M
-35.78%4.85M
-20.84%3M
Gross profit
136.33%130.56M
54.59%92.93M
29.33%240.84M
111.29%71.7M
-14.60%53.78M
74.50%55.25M
4.27%60.11M
14.85%186.22M
-65.89%33.93M
208.74%62.98M
Operating expense
-4.61%173.61M
-6.16%171.75M
1.13%722.86M
-2.75%176.85M
-2.48%180.99M
-2.76%181.99M
14.25%183.02M
-10.24%714.79M
-55.76%181.86M
38.27%185.59M
Selling and administrative expenses
24.20%89.34M
17.77%83.56M
24.34%295.14M
23.89%79.32M
22.80%70.74M
22.57%71.93M
24.35%70.95M
21.55%237.37M
18.12%64.02M
15.66%57.61M
-Selling and marketing expense
99.77%22.71M
68.46%16.93M
----
----
69.34%13.07M
18.10%11.37M
--10.05M
----
----
--7.72M
-General and administrative expense
10.02%66.63M
9.40%66.63M
----
----
15.60%57.67M
23.44%60.56M
--60.9M
----
----
--49.89M
Research and development costs
-23.43%84.27M
-21.31%88.19M
-10.41%427.72M
-17.23%97.54M
-13.85%110.25M
-14.33%110.06M
8.67%112.07M
-20.57%477.42M
-66.98%117.84M
51.60%127.98M
Operating profit
66.04%-43.05M
35.87%-78.82M
8.81%-482.02M
28.91%-105.15M
-3.75%-127.21M
18.49%-126.75M
-19.87%-122.91M
16.65%-528.57M
52.53%-147.93M
-7.72%-122.61M
Net non-operating interest income expense
-71.77%-6.86M
-1.31%-5.9M
-12.08%-18.79M
44.06%-5.17M
54.65%-3.81M
-1,035.83%-4M
-1,416.52%-5.82M
-802.72%-16.77M
-2,095.68%-9.24M
-1,621.01%-8.4M
Non-operating interest income
28.22%9.94M
55.56%9.18M
----
----
216.24%9.33M
1,689.61%7.75M
--5.9M
----
----
--2.95M
Non-operating interest expense
43.04%16.8M
28.62%15.07M
----
----
15.79%13.14M
195,650.00%11.75M
--11.72M
----
----
--11.35M
Total other finance cost
----
----
12.08%18.79M
----
----
----
----
802.72%16.77M
----
----
Other net income (expense)
100.91%17K
56,240.00%174.03M
25.09%-5.2M
-20.09%-532K
-96.93%-2.5M
-22.93%-1.86M
91.66%-310K
25.25%-6.94M
90.98%-443K
66.53%-1.27M
Earnings from equity interest
--0
--0
52.44%-4.26M
102.40%45K
-6.37%-1.77M
42.47%-1.23M
60.31%-1.3M
-14.70%-8.95M
58.69%-1.87M
49.07%-1.67M
Special income (charges)
--18K
--173.66M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
---18K
---173.66M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
99.84%-1K
-61.87%376K
-147.21%-946K
-140.38%-577K
-283.84%-728K
-199.05%-626K
317.66%986K
234.59%2M
476.05%1.43M
175.86%396K
Income before tax
62.37%-49.89M
169.22%89.32M
8.38%-506.02M
29.66%-110.86M
-0.94%-133.52M
15.31%-132.6M
-21.95%-129.04M
13.85%-552.28M
50.13%-157.61M
-12.99%-132.28M
Income tax
-46.32%102K
-65.38%180K
-81.51%968K
-94.11%61K
-77.77%197K
-93.93%190K
182.61%520K
74.48%5.24M
-60.65%1.04M
406.29%886K
Net income
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
Net income continuous Operations
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
Minority interest income
Net income attributable to the parent company
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
62.35%-49.99M
168.80%89.14M
9.06%-506.98M
30.09%-110.92M
-0.41%-133.71M
16.85%-132.79M
-22.23%-129.56M
13.44%-557.52M
50.22%-158.65M
-13.58%-133.16M
Basic earnings per share
63.47%-0.8
167.44%1.45
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
-11.50%-2.23
Diluted earnings per share
63.47%-0.8
165.12%1.4
10.48%-8.37
31.32%-1.82
1.35%-2.2
18.28%-2.19
-20.11%-2.15
15.08%-9.35
50.93%-2.65
-11.50%-2.23
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 139.98%138.16M51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M172.77%65.98M
Operating revenue 139.98%138.16M51.87%96.12M22.22%249.38M85.55%71.96M-14.26%56.57M57.52%57.57M0.89%63.29M13.30%204.04M-63.76%38.78M172.77%65.98M
Cost of revenue 226.86%7.59M0.50%3.19M-52.06%8.54M-94.64%260K-7.27%2.78M-52.46%2.32M-37.49%3.18M-0.67%17.81M-35.78%4.85M-20.84%3M
Gross profit 136.33%130.56M54.59%92.93M29.33%240.84M111.29%71.7M-14.60%53.78M74.50%55.25M4.27%60.11M14.85%186.22M-65.89%33.93M208.74%62.98M
Operating expense -4.61%173.61M-6.16%171.75M1.13%722.86M-2.75%176.85M-2.48%180.99M-2.76%181.99M14.25%183.02M-10.24%714.79M-55.76%181.86M38.27%185.59M
Selling and administrative expenses 24.20%89.34M17.77%83.56M24.34%295.14M23.89%79.32M22.80%70.74M22.57%71.93M24.35%70.95M21.55%237.37M18.12%64.02M15.66%57.61M
-Selling and marketing expense 99.77%22.71M68.46%16.93M--------69.34%13.07M18.10%11.37M--10.05M----------7.72M
-General and administrative expense 10.02%66.63M9.40%66.63M--------15.60%57.67M23.44%60.56M--60.9M----------49.89M
Research and development costs -23.43%84.27M-21.31%88.19M-10.41%427.72M-17.23%97.54M-13.85%110.25M-14.33%110.06M8.67%112.07M-20.57%477.42M-66.98%117.84M51.60%127.98M
Operating profit 66.04%-43.05M35.87%-78.82M8.81%-482.02M28.91%-105.15M-3.75%-127.21M18.49%-126.75M-19.87%-122.91M16.65%-528.57M52.53%-147.93M-7.72%-122.61M
Net non-operating interest income expense -71.77%-6.86M-1.31%-5.9M-12.08%-18.79M44.06%-5.17M54.65%-3.81M-1,035.83%-4M-1,416.52%-5.82M-802.72%-16.77M-2,095.68%-9.24M-1,621.01%-8.4M
Non-operating interest income 28.22%9.94M55.56%9.18M--------216.24%9.33M1,689.61%7.75M--5.9M----------2.95M
Non-operating interest expense 43.04%16.8M28.62%15.07M--------15.79%13.14M195,650.00%11.75M--11.72M----------11.35M
Total other finance cost --------12.08%18.79M----------------802.72%16.77M--------
Other net income (expense) 100.91%17K56,240.00%174.03M25.09%-5.2M-20.09%-532K-96.93%-2.5M-22.93%-1.86M91.66%-310K25.25%-6.94M90.98%-443K66.53%-1.27M
Earnings from equity interest --0--052.44%-4.26M102.40%45K-6.37%-1.77M42.47%-1.23M60.31%-1.3M-14.70%-8.95M58.69%-1.87M49.07%-1.67M
Special income (charges) --18K--173.66M--------------0--0------------
-Less:Other special charges ---18K---173.66M--------------------------------
Other non- operating income (expenses) 99.84%-1K-61.87%376K-147.21%-946K-140.38%-577K-283.84%-728K-199.05%-626K317.66%986K234.59%2M476.05%1.43M175.86%396K
Income before tax 62.37%-49.89M169.22%89.32M8.38%-506.02M29.66%-110.86M-0.94%-133.52M15.31%-132.6M-21.95%-129.04M13.85%-552.28M50.13%-157.61M-12.99%-132.28M
Income tax -46.32%102K-65.38%180K-81.51%968K-94.11%61K-77.77%197K-93.93%190K182.61%520K74.48%5.24M-60.65%1.04M406.29%886K
Net income 62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M
Net income continuous Operations 62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M
Minority interest income
Net income attributable to the parent company 62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 62.35%-49.99M168.80%89.14M9.06%-506.98M30.09%-110.92M-0.41%-133.71M16.85%-132.79M-22.23%-129.56M13.44%-557.52M50.22%-158.65M-13.58%-133.16M
Basic earnings per share 63.47%-0.8167.44%1.4510.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65-11.50%-2.23
Diluted earnings per share 63.47%-0.8165.12%1.410.48%-8.3731.32%-1.821.35%-2.218.28%-2.19-20.11%-2.1515.08%-9.3550.93%-2.65-11.50%-2.23
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Cancer Research
Cancer Research
Intraday-0.34%